<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Anticardiolipin antibodies (aCL) have been demonstrated in a large spectrum of <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, its occurrence in childhood, in particular in juvenile idiopathic <z:hpo ids='HP_0001369'>arthritis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e>), is not well established </plain></SENT>
<SENT sid="2" pm="."><plain>The present study addressed the frequency and clinical significance of aCL in a group of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: aCL (IgG and IgM isotypes), <z:hpo ids='HP_0003493'>antinuclear antibodies</z:hpo> (ANA), and rheumatoid factor (RF) were determined in 86 children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> (33 systemic, 31 polyarticular and 22 oligoarticular <z:hpo ids='HP_0003674'>onset</z:hpo> type) </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty-two juvenile systemic erythematosus <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> patients (JSLE) and 52 healthy children formed the control groups </plain></SENT>
<SENT sid="5" pm="."><plain>The disease activity and functional status of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> patients were scored to study their possible associations with the presence of aCL </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Serum aCL levels above the <z:mpath ids='MPATH_458'>normal</z:mpath> range were detected in 28/86 JIA patients (32.5%), 12/32 JSLE patients (37.5%), and 3/52 healthy children (6%) </plain></SENT>
<SENT sid="7" pm="."><plain>Positive aCL levels were slightly or moderately elevated (usually below 30 GPL and 20 MPL) </plain></SENT>
<SENT sid="8" pm="."><plain>The presence of aCL was not associated with the presence of ANA or RF </plain></SENT>
<SENT sid="9" pm="."><plain>Associations between aCL and clinical parameters, such as disease <z:hpo ids='HP_0003674'>onset</z:hpo>, duration, activity or severity could not be established </plain></SENT>
<SENT sid="10" pm="."><plain>No <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> patient had vascular <z:mp ids='MP_0005048'>thrombosis</z:mp>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> or "<z:hpo ids='HP_0000965'>livedo reticularis</z:hpo>" </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: aCL occurred in low titers in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> children, in a similar frequency to that observed in JSLE </plain></SENT>
<SENT sid="12" pm="."><plain>No association with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e> clinical parameters or the clinical features classically linked to the <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome were observed </plain></SENT>
</text></document>